Some Good News - Health Canada has approved Ib... - CLL Support
Some Good News - Health Canada has approved Ibrutinib & Venetoclax as a first line treatment for previously untreated CLL/SLL.
You need to be a member of this community to see this post.
Read more about...
8 Replies
You need to be a member of this community to see hidden responses.
Not what you're looking for?
You may also like...
Venetoclax plus obinutuzumab - the first chemotherapy-free, fixed-duration first line CLL treatment approved by Health Canada
* VENCLEXTA® (venetoclax) plus obinutuzumab is the first chemotherapy-free,
fixed-duration...
Health Canada approves Ibrutinib plus Rituximab for First Line Treatment of Patients with Chronic Lymphocytic Leukemia (CLL)
ca/news-releases/health-canada-approves-imbruvica-r-ibrutinib-plus-rituximab-for-the-treatment-of-pa
UK NICE Approves Ibrutinib +Venetoclax for First Line treatment for ALL Patients from today
this effective treatment is now available for ALL CLL patients as their first treatment if their...
Adding Venetoclax to Obinutuzumab Prolongs Progression-Free Survival in Previously Untreated CLL
patients with previously untreated CLL and co-existing comorbidities, a fixed-duration regimen...
Zanubrutinib Bests Bendamustine-Rituximab in Previously Untreated CLL/SLL
utinib-bests-bendamustine-rituximab-cll-sll-previously-untreated/
Related Posts
B-PLL: Ibrutrinib Monotherapy or Obinutuzumab (aka Gazyva) & Venetoclax Combination as first-line treatment for transformed CLL
First line above at 69Y: Venetoclax vs Ibrutinib vs BR
Curious to know the preferred first-line treatment for CLL in other countries 
FDA Frontline Approval of Venetoclax and Obinituzumab in the USA- Good News! BTK inhibitor therapy is effective in patients with CLL resistant to venetoclax
